FX-345

N/A

Report date: 2024/01/15 10:58:20
NME

Base Information

Drug NameFX-345
Drug Alias NameFX345
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlycogen synthase kinase-3 inhibitorsStem cells stimulants
TargetsGlycogen synthase kinase-3
Therapy Area/IndicationsHearing Loss, Sensorineural
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesFrequency Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesFrequency Therapeutics
Inactive CompaniesN/A
Active IndicationsHearing Loss, Sensorineural
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A